Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01174199
Title Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Recruitment Terminated
Gender male
Phase Phase I
Variant Requirements No
Sponsors Roswell Park Cancer Institute

prostate adenocarcinoma


Temsirolimus + Vorinostat

Age Groups: adult
Covered Countries USA

No variant requirements are available.